ALISSA MATTHEWS: Open Payments
NPI 1265451884 · CEDAR SPRINGS,, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 60 payments from 19 companies in 2025. Trend: 2023 $750 · 2024 $1,270 · 2025 $1,123
Food & beverage: $1,109Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $178 |
| Exact Sciences Corporation | 3 | $113 |
| Novo Nordisk Inc | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Lilly USA, LLC | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $84 |
| PFIZER INC. | 4 | $81 |
| Supernus Pharmaceuticals, Inc. | 4 | $63 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Dexcom, Inc. | 2 | $53 |
Products named: The Cologuard Plus Collection Kit, VRAYLAR, REXULTI, MOUNJARO, Qelbree, FARXIGA, TRELEGY ELLIPTA, Wegovy.
Industry payments across MI — which companies pay providers there.
